Fosaprepitant Dimeglumine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

35 API Suppliers, 16 USDMF, 3 JDMF, 6 EU WC, 12 NDC API, 23 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

INTERMEDIATES

3 Intermediates Suppliers

3 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

50 FDF Dossiers, 24 FDA Orange Book, 5 Europe, 1 Canada, 8 Australia, 3 South Africa, 9 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - EQ 115MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, POWDER;INTRAVENOUS - EQ 150MG BASE/VIAL

RELATED EXCIPIENT COMPANIES

1 Nanjing Well Pharmaceutical, 3 Actylis, 1 BASF, 1 DFE Pharma, 3 Gangwal Chemicals, 7 Kerry, 1 Microlex e.U, 1 Nanjing Bold Chemical, 6 Seppic

EXCIPIENTS BY APPLICATIONS

10 Solubilizers, 6 Parenteral, 5 Fillers, Diluents & Binders, 3 Topical, 3 Co-Processed Excipients, 3 Direct Compression, 3 Emulsifying Agents, 2 Thickeners and Stabilizers, 2 Film Formers & Plasticizers, 2 Surfactant & Foaming Agents, 1 Granulation, 1 Rheology Modifiers, 1 API Stability Enhancers